Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations

Nutrition

Volumn 32, Issue 1, 2016, Pages 3-8

  Huang, Ya Qing ^a   Lu, Xin ^b   Min, Han ^a   Wu, Qian Qian ^a   Shi, Xiao Ting ^a   Bian, Kang Qi ^a   Zou, Xiao Ping ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Asian populations; Cohort studies; Green tea; Liver cancer; Meta analysis

Indexed keywords

ASIAN; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CHINA; HUMAN; JAPAN; LIVER CANCER; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SEX DIFFERENCE; SINGAPORE; TEA; ASIA; CAMELLIA SINENSIS; DIET; FEMALE; LIVER NEOPLASMS; MALE; META ANALYSIS;

PLANT EXTRACT; TEA;

ASIA; CAMELLIA SINENSIS; DIET; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; PLANT EXTRACTS; TEA;

EID: 84959268458     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.05.021     Document Type: Review

References (46)

1. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015, 136:E359-E386.
2. Yu M.C., Yuan J.M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004, 127:S72-S78.
3. Kuroda Y., Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 1999, 436:69-97.
4. Landis-Piwowar K.R., Huo C., Chen D., Milacic V., Shi G., Chan T.H., et al. A novel prodrug of the green tea polyphenol -epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 2007, 67:4303-4310.
5. Qin G., Gopalan-Kriczky P., Su J., Ning Y., Lotolikar P.D. Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett 1997, 112:149-154.
6. Sakata R., Ueno T., Nakamura T., Sakamoto M., Torimura T., Sata M. Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. J Hepatol 2004, 40:52-59.
7. Nishikawa T., Nakajima T., Moriguchi M., Jo M., Sekoguchi S., Ishii M., et al. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 2006, 44:1074-1082.
8. Yuan J.M. Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr 2013, 98:1676S-1681S.
9. Fon Sing M., Yang W.S., Gao S., Gao J., Xiang Y.B. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. Eur J Cancer Prev 2011, 20:157-165.
10. Inoue M., Yoshimi I., Sobue T., Tsugane S. JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005, 97:293-300.
11. Nechuta S., Shu X.O., Li H.L., Yang G., Ji B.T., Xiang Y.B., et al. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study. Am J Clin Nutr 2012, 96:1056-1063.
12. Johnson S., Koh W.P., Wang R., Govindarajan S., Yu M.C., Yuan J.M. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 2011, 22:503-510.
13. Inoue M., Kurahashi N., Iwasaki M., Shimazu T., Tanaka Y., Mizokami M., et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009, 18:1746-1753.
14. Ui A., Kuriyama S., Kakizaki M., Sone T., Nakaya N., Ohmori-Matsuda K., et al. Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Causes Control 2009, 20:1939-1945.
15. Wang N., Zheng Y., Jiang Q., Yu X., Chen Y. Tea and reduced liver cancer mortality. Epidemiology 2008, 19:761.
16. Iso H., Kubota Y. Nutrition and disease in the Japan Collaborative Cohort study for evaluation of cancer (JACC). Asian Pac J Cancer Prev 2007, 8:35-80.
17. Shimazu T., Tsubono Y., Kuriyama S., Ohmori K., Koizumi Y., Nishino Y., et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005, 116:150-154.
18. Nagano J., Kono S., Preston D.L., Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki. Cancer Causes Control 2001, 12:501-508.
19. Nakachi K., Matsuyama S., Miyake S., Suganuma M., Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000, 13:49-54.
20. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
21. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557.
22. Hedges L.V., Pigott T.D. The power of statistical tests in meta-analysis. Psychol Methods 2001, 6:203-217.
23. Greenland S., Longnecker M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992, 135:1301-1309.
24. Orsini N., Bellocco R., Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006, 6:40-57.
25. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
26. Thornton A., Lee P. Publication bias in meta-analysis: Its causes and consequences. J Clin Epidemiol 2000, 53:207-216.
27. Yu F., Jin Z., Jiang H., Xiang C., Tang J., Li T., et al. Tea consumption and the risk of five major cancers: a dose-response meta-analysis of prospective studies. BMC Cancer 2014, 14:197.
28. Fujiki H., Suganuma M., Okabe S., Komori A., Sueoka E., Sueoka N., et al. Japanese green tea as a cancer preventive in humans. Nutr Rev 1996, 54:S67-S70.
29. Ahmad N., Mukhtar H. Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 1999, 57:78-83.
30. Higdon J.V., Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003, 43:89-143.
31. Hakim I.A., Harris R.B., Brown S., Chow H.H., Wiseman S., Agarwal S., et al. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J Nutr 2003, 133:3303S-3309S.
32. Yamane T., Takahashi T., Kuwata K., Oya K., Inagake M., Kitao Y., et al. Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 1995, 55:2081-2084.
33. Ju J., Hong J., Zhou J.N., Pan Z., Bose M., Liao J., et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 2005, 65:10623-10631.
34. Carter O., Dashwood R.H., Wang R., Dashwood W.M., Orner G.A., Fischer K.A., et al. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutr Cancer 2007, 58:60-65.
35. Yang C.S., Wang X., Lu G., Picinich S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009, 9:429-439.
36. Dreosti I.E., Wargovich M.J., Yang C.S. Inhibition of carcinogenesis by tea: the evidence from experimental studies. Crit Rev Food Sci Nutr 1997, 37:761-770.
37. Lu Y.P., Lou Y.R., Lin Y., Shih W.J., Huang M.T., Yang C.S., et al. Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice) relationship to decreased tissue fat. Cancer Res 2001, 61:5002-5009.
38. Mazzanti G., Menniti-Ippolito F., Moro P.A., Cassetti F., Raschetti R., Santuccio C., et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009, 65:331-341.
39. Patel S.S., Beer S., Kearney D.L., Phillips G., Carter B.A. Green tea extract: a potential cause of acute liver failure. World J Gastroenterol 2013, 19:5174-5177.
40. He P., Noda Y., Sugiyama K. Green tea suppresses lipopolysaccharide induced liver injury in D-galactosamine-sensitized rats. J Nutr 2001, 131:1560-1567.
41. Dobrzynska I., Sniecinska A., Skrzydlewska E., Figaszewski Z. Green tea modulation of the biochemical and electric properties of rat liver cells that were affected by ethanol and aging. Cell Mol Biol Lett 2004, 9:709-721.
42. Skrzydlewska E., Ostrowska J., Stankiewicz A., Farbiszewski R. Green tea as a potent antioxidant in alcohol intoxication. Addict Biol 2002, 7:307-314.
43. Augustyniak A., Waszkiewicz E., Skrzydlewska E. Preventive action of green tea from changes in the liver antioxidant abilities of different aged rats intoxicated with ethanol. Nutrition 2005, 21:925-932.
44. Fattovich G., Bortolotti F., Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008, 48:335-352.
45. Patrick L. Hepatitis C: epidemiology and review of complementary/alternative medicine treatments. Altern Med Rev 1999, 4:220-238.
46. Xu J., Wang J., Deng F., Hu Z., Wang H. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Res 2008, 78:242-249.